Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer cells through ERM activation

Resistin: Insulin resistance to malignancy

(2015) Pilar Codoñer-Franch et al.   CLINICA CHIMICA ACTA

Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin

(2014) Chen-Chieh Yang et al.   BMC CANCER

Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives

(2013) Maria Dalamaga   Biomarkers in Medicine

Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf–Hirschhorn syndrome candidate 1/Twist pathway

(2013) Chih-Hsin Kuo et al.   CARCINOGENESIS

Serum resistin: A biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters

(2013) Maria Dalamaga et al.   CLINICAL BIOCHEMISTRY

Resistin Promotes the Expression of Vascular Endothelial Growth Factor in Ovary Carcinoma Cells

(2013) Li Pang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hyperresistinemia is associated with postmenopausal breast cancer

(2013) Maria Dalamaga et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification

(2012) Yi-Chen Lee et al.   GYNECOLOGIC ONCOLOGY

The role of renal water channels in health and disease

(2012) Ross P. Holmes   MOLECULAR ASPECTS OF MEDICINE

Relationship of resistin levels with endometrial cancer risk

(2011) M. HLAVNA et al.   NEOPLASMA

Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation

(2010) Hae Jong Kim et al.   BJU INTERNATIONAL

Adipocytokine resistin and breast cancer risk

(2010) Chien-An Sun et al.   BREAST CANCER RESEARCH AND TREATMENT

Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition

(2010) Melissa G. Mendez et al.   FASEB JOURNAL

Initiation of malignancy by duodenal contents reflux and the role of ezrin in developing esophageal squamous cell carcinoma

(2009) Zhi-Qiang Ling et al.   CANCER SCIENCE

The role of resistin as a regulator of inflammation: Implications for various human pathologies

(2009) Mária Filková et al.   CLINICAL IMMUNOLOGY

RNAi-mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC-7901

(2009) Hong Jian WANG et al.   Journal of Digestive Diseases

Young mothers who choose to breast feed: the importance of being part of a supportive breast-feeding community

(2009) Amy Brown et al.   MIDWIFERY

Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells

(2008) Qiong Li et al.   CANCER LETTERS

Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells

(2008) F. A. Wald et al.   JOURNAL OF CELL SCIENCE

The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC

(2008) L Ren et al.   ONCOGENE

Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma

(2007) Stefano Ferrari et al.   PEDIATRIC BLOOD & CANCER